Genetically attenuated live virus [15,48]
Whole inactivated virion preparations [49]
Recombinant subunit (glycoprotein) vaccines [50,51]
Replicating nonpathogenic vectors that express one or more HSV antigens [52–54]
DNA plasmids expressing one or more HSV proteins (genetic immunization) [31,55–58]